In this Feb. 6, 2020 file photo, a man buys a face mask at a pharmacy in Kitwe, Zambia. Zambia faces a Friday deadline to clear debt owed to external investors who have rejected the country’s request for deferral of an overdue $42.5 million interest payment amid the coronavirus pandemic.
The United States will cut $50 million worth of medical aid a year to Zambia because of “systematic” theft of the aid in past years and the government’s failure to crack down on that, the U.S. ambassador said Thursday.
The U.S. had discovered in 2021 that medicines and medical supplies that were meant to be provided free to Zambians had been taken and were being sold by pharmacies across the southern African country, U.S. Ambassador to Zambia Michael Gonzales said at a press briefing.
He said that a U.S. investigation of around 2,000 pharmacies in Zambia between 2021 and 2023 found that nearly half of them were selling medicines and products paid for by U.S. aid funds.
The Zambian government had failed to do enough to address the corruption after the U.S. informed it of the theft scandal in April 2024, Gonzales said.
“For more than a year, the United States has requested tangible action by the government of Zambia to respond to the countrywide, systematic theft of these products,” he said. “In the face of minimal responsive action by the government, the United States is taking necessary steps to safeguard and ensure the accountability of American taxpayer funds.”
Zambian Health Minister Elijah Muchima said the government acknowledged the concerns of the U.S. and was committed to “resolving this unfortunate issue.” The government had fired, suspended or arrested officials implicated and was finalizing a report on the theft of medicines, but had to respect the legal process, Muchima said.
The $50 million is part of $128 million the U.S. gives to Zambia a year for medicines, medical supplies and other support for its health sector. Gonzales said the cuts would affect medications for HIV, tuberculosis and malaria, three critical diseases affecting Zambians.
The action was separate to U.S. President Donald Trump’s decision to cut U.S. foreign aid across the world, Gonzales said.
He said that the U.S. investigation into the theft also found that medications and supplies paid for by the Zambia government, the Global Fund and other international donors were being sold in pharmacies.
Zambia is burdened by heavy debts to China and other nations and relies on aid. The U.S. had been giving it a total of $600 million a year in health and development aid and funded approximately a third of the Zambian public health system, Gonzales said.
The ambassador said he had recommended to officials in Washington that the U.S. start cutting the aid from January next year to give Zambia time to plan new procurements of the life-saving drugs.
How useful was this article ?
Click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?
Related Articles
Legal Hurdles in a Medical Malpractice Claim
Believers Say Microdosing Psychedelics Helps Them. Scientists Are Trying To Measure The Claims – Associated Press
Holistic Approaches That Address the Root Causes of Chronic Pain
LL-37 Peptide: A Multifaceted Tool for Scientific Exploration
For older adults taking medications, summer heat can be especially dangerous – Cronkite News
Common Childhood Illnesses: Symptoms, Treatment, and When To Worry
Recent Articles
Huge crowd piles pressure on Dutch government to seek an end to Israel’s campaign in Gaza – Associated Press
Trump’s clash with the courts raises prospect of showdown over separation of powers – Associated Press
Republicans look to get Trump’s big bill back on track with rare Sunday committee session – Associated Press
APS provides notice it wants to increase rates (again)
Opinion: The Mask Slips Over Afrikaner Refugees – Gregory Hood
Trump Administration Raises Charter School Funding to $500 Million – The Epoch Times
Back to Home Page